International Stem Cell CORP (ISCO) stock
ISCOOTCPharmaceutical PreparationsFiscal year ends December 31
$0.28+0.00 (+0.89%)
Close on Oct 19, 2026Market cap $2.27MP/E –Yield –
Earnings
International Stem Cell's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of International Stem Cell's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q1 FY2015ended Mar 31, 2015 | Apr 1, 2015during market hours | – | – | – | Filing |
| Q3 FY2014ended Sep 30, 2014 | Nov 13, 2014before the open | – | – | – | Filing |
| Q2 FY2014ended Jun 30, 2014 | Aug 12, 2014before the open | – | – | – | Filing |
| Q1 FY2014ended Mar 31, 2014 | May 13, 2014before the open | – | – | – | Filing |
| Q4 FY2013ended Dec 31, 2013 | Mar 18, 2014before the open | – | – | – | Filing |
| Q3 FY2013ended Sep 30, 2013 | Nov 13, 2013before the open | – | – | – | Filing |
| Q2 FY2013ended Jun 30, 2013 | Aug 8, 2013before the open | – | – | – | Filing |
| Q1 FY2013ended Mar 31, 2013 | May 14, 2013before the open | – | – | – | Filing |
| Q4 FY2012ended Dec 31, 2012 | Mar 27, 2013before the open | – | – | – | Filing |
| Q3 FY2012ended Sep 30, 2012 | Nov 9, 2012during market hours | – | – | – | Filing |
| Q2 FY2012ended Jun 30, 2012 | Aug 9, 2012before the open | – | – | – | Filing |
| Q4 FY2011ended Dec 31, 2011 | Mar 22, 2012during market hours | – | – | – | Filing |
| Q1 FY2011ended Mar 31, 2011 | May 25, 2011during market hours | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
International Stem Cell has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When International Stem Cell puts a forecast in an earnings release, it is listed here with the exact sentence.
See a number that looks wrong?